Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.51 |
| ▸ | HPGD | P15428 | 5/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.51 |
| ▸ | GLA | P06280 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | ABCB1 | P08183 | 9/20 | 0.44 |
| ▸ | ABCG2 | Q9UNQ0 | 6/20 | 0.43 |
| ▸ | CA12 | O43570 | 3/20 | 0.41 |
| ▸ | CA9 | Q16790 | 3/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3399044 | 0.90 | ALDH1A1 (0.50) | ALDH1A1HPGDKDM4EMEN1KMT2A | |
| SCHEMBL14707476 | 0.86 | ALDH1A1 (0.53) | ALDH1A1HPGDKDM4EMEN1KMT2A | |
| SCHEMBL12256226 | 0.83 | L3MBTL1 (0.53) | ALDH1A1HPGDKDM4EMEN1KMT2A | |
| SCHEMBL6880564 | 0.83 | ALDH1A1 (0.56) | ALDH1A1HPGDKDM4EMEN1KMT2A | |
| SCHEMBL14440745 | 0.81 | KDM4E (0.50) | ALDH1A1HPGDKDM4EMEN1KMT2A | |
| SCHEMBL3404132 | 0.81 | ALDH1A1 (0.43) | ALDH1A1HPGDKDM4EMEN1KMT2A | |
| SCHEMBL13159325 | 0.81 | KDM4E (0.43) | ALDH1A1HPGDKDM4EMEN1KMT2A | |
| SCHEMBL13159644 | 0.81 | ALDH1A1 (0.43) | ALDH1A1HPGDKDM4EMEN1KMT2A | |
| SCHEMBL13695982 | 0.80 | KDM4E (0.47) | ALDH1A1HPGDKDM4EMEN1KMT2A | |
| SCHEMBL15910310 | 0.80 | TSHR (0.58) | ALDH1A1HPGDKDM4EMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8808960-B2 | Compound and chemically amplified positive resist composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-08-19 | — | — | US | disclosed |
| US-20100233628-A1 | COMPOUND AND CHEMICALLY AMPLIFIED POSITIVE RESIST COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-09-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100233628-A1 | COMPOUND AND CHEMICALLY AMPLIFIED POSITIVE RESIST COMPOSITION | HRH3, C9, H1-2 | ALDH1A1 1743/4885HPGD 3191/4885KDM4E 4077/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.